Replimune Group Accounts Payable

Replimune Group (REPL) currently reports a accounts payable of $4.3M as of June 2026. That compares with $15M in the prior-year period — down 72.5% year over year. Use the charts on this page to explore Replimune Group's accounts payable history and peer comparisons.

Replimune Group's accounts payable decreased from $15M to $4.3M — a 72.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Replimune Group reported $4.3M in accounts payable as of June 2026. That compares with $15M in the prior-year period — down 72.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $4.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Replimune Group, and consider following REPL for alerts when major investors trade the stock.

Replimune Group is classified in the Healthcare sector. On accounts payable, it currently shows $4.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing REPL with unrelated industries.